David W. Warne

476 total citations
14 papers, 241 citations indexed

About

David W. Warne is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David W. Warne has authored 14 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 8 papers in Public Health, Environmental and Occupational Health and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David W. Warne's work include Ovarian function and disorders (9 papers), Reproductive Biology and Fertility (6 papers) and Hormonal and reproductive studies (3 papers). David W. Warne is often cited by papers focused on Ovarian function and disorders (9 papers), Reproductive Biology and Fertility (6 papers) and Hormonal and reproductive studies (3 papers). David W. Warne collaborates with scholars based in Switzerland, United States and United Kingdom. David W. Warne's co-authors include Ernest Loumaye, Colin M. Howles, Pierre Bouloux, Hiroshi Okada, Andrea Borini, F. Olivennes, Geoffrey Trew, Pablo Arriagada, Frank J. Broekmans and Philip Winn and has published in prestigious journals such as Neuroscience, Human Reproduction and Fertility and Sterility.

In The Last Decade

David W. Warne

14 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Warne Switzerland 6 200 79 64 62 33 14 241
Marzia Barberi Italy 11 194 1.0× 150 1.9× 62 1.0× 96 1.5× 40 1.2× 14 342
Alessandro Mongioí Italy 10 286 1.4× 127 1.6× 131 2.0× 70 1.1× 45 1.4× 18 374
Leandro Soriano-Guillén Spain 5 120 0.6× 22 0.3× 60 0.9× 132 2.1× 132 4.0× 6 298
Danielle S. Bessa Brazil 8 252 1.3× 52 0.7× 58 0.9× 214 3.5× 208 6.3× 9 411
A.M. Comaru-Schally Israel 6 80 0.4× 16 0.2× 172 2.7× 56 0.9× 28 0.8× 9 317
Diana L. Cousminer Finland 3 44 0.2× 38 0.5× 31 0.5× 35 0.6× 24 0.7× 3 146
Susanna Apter Finland 6 203 1.0× 280 3.5× 22 0.3× 77 1.2× 7 0.2× 7 420
Deborah Papadopoulou United Kingdom 7 173 0.9× 33 0.4× 107 1.7× 73 1.2× 93 2.8× 12 272
Emerson Barchi Cordts Brazil 10 205 1.0× 193 2.4× 16 0.3× 71 1.1× 105 3.2× 15 342
Philipp Wartenberg Germany 8 27 0.1× 11 0.1× 20 0.3× 49 0.8× 18 0.5× 12 140

Countries citing papers authored by David W. Warne

Since Specialization
Citations

This map shows the geographic impact of David W. Warne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Warne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Warne more than expected).

Fields of papers citing papers by David W. Warne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Warne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Warne. The network helps show where David W. Warne may publish in the future.

Co-authorship network of co-authors of David W. Warne

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Warne. A scholar is included among the top collaborators of David W. Warne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Warne. David W. Warne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Warne, David W., et al.. (2024). Revie ⊕: Impact of a resource-based life review intervention on patients with advanced cancer: A waitlist controlled trial. European Journal of Oncology Nursing. 68. 102506–102506. 2 indexed citations
2.
Hemptinne, Quentin de, Panagiotis Xaplanteris, Antoine Guédès, et al.. (2022). Magmaris Resorbable Magnesium Scaffold Versus Conventional Drug-Eluting Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity-Score-Matching Comparison. Cardiovascular revascularization medicine. 43. 28–35. 5 indexed citations
3.
Olivennes, F., Geoffrey Trew, Andrea Borini, et al.. (2014). Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa. Reproductive BioMedicine Online. 30(3). 248–257. 36 indexed citations
4.
Warne, David W., et al.. (2011). Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysis.. PubMed. 56(1-2). 31–8. 3 indexed citations
5.
Howles, Colin M., Verónica Alam, Donald R. Tredway, Roy Homburg, & David W. Warne. (2009). Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility. Reproductive BioMedicine Online. 20(2). 182–190. 9 indexed citations
6.
7.
Tredway, Donald R., David W. Warne, Aliza Eshkol, & Verónica Alam. (2007). Correlation between luteal serum progesterone levels and pregnancy in ovulation induction. Fertility and Sterility. 88. S195–S195. 1 indexed citations
8.
9.
10.
Mathews, T J, et al.. (2004). Early evidence of efficacy and safety for a novel sustained-release recombinant human follicle stimulating hormone (FSH-SR). Fertility and Sterility. 82. S48–S48. 1 indexed citations
11.
12.
Bouloux, Pierre, David W. Warne, & Ernest Loumaye. (2002). Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertility and Sterility. 77(2). 270–273. 61 indexed citations
13.
Loumaye, Ernest, et al.. (1997). O-105. Clinical use of recombinant human LH. Human Reproduction. 12(Suppl_2). 50–51. 1 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marzia Barberi Breakdown of academic impact, for papers by Alessandro Mongioí Breakdown of academic impact, for papers by Leandro Soriano-Guillén Breakdown of academic impact, for papers by Danielle S. Bessa Breakdown of academic impact, for papers by A.M. Comaru-Schally Breakdown of academic impact, for papers by Diana L. Cousminer Breakdown of academic impact, for papers by Susanna Apter Breakdown of academic impact, for papers by Deborah Papadopoulou Breakdown of academic impact, for papers by Emerson Barchi Cordts Breakdown of academic impact, for papers by Philipp Wartenberg
Rankless by CCL
2026